Challice Bonifant

Assistant Professor

19982020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Challice Bonifant is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

The future of cellular immunotherapy for childhood leukemia

Bonifant, C. L. & Tasian, S. K., Feb 1 2020, In : Current opinion in pediatrics. 32, 1, p. 13-25 13 p.

Research output: Contribution to journalReview article

  • T-cell Activity against AML Improved by Dual-Targeted T Cells Stimulated through T-cell and IL7 Receptors

    Krawczyk, E., Zolov, S. N., Huang, K. & Bonifant, C. L., Apr 2019, In : Cancer Immunology Research. 7, 4, p. 683-692 10 p.

    Research output: Contribution to journalArticle

  • Advances in immunotherapy for pediatric acute myeloid leukemia

    Bonifant, C. L., Velasquez, M. P. & Gottschalk, S., Jan 2 2018, In : Expert Opinion on Biological Therapy. 18, 1, p. 51-63 13 p.

    Research output: Contribution to journalReview article

  • Programmed cell death protein 1 activation preferentially inhibits CD28.CAR–T cells

    Zolov, S. N., Rietberg, S. P. & Bonifant, C. L., Oct 2018, In : Cytotherapy. 20, 10, p. 1259-1266 8 p.

    Research output: Contribution to journalArticle

  • Redirecting T cells to hematological malignancies with bispecific antibodies

    Velasquez, M. P., Bonifant, C. L. & Gottschalk, S., Jan 4 2018, In : Blood. 131, 1, p. 30-38 9 p.

    Research output: Contribution to journalReview article